Dolby Laboratories, Inc.
DLB
$54.06
-$0.06-0.11%
NYSE
| 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 77.99% | 8.10% | 7.08% | -49.81% | 35.34% |
| Total Depreciation and Amortization | 0.12% | 9.11% | 0.73% | -0.12% | -3.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.26% | -48.92% | 169.15% | -32.94% | 12.76% |
| Change in Net Operating Assets | -27.48% | -364.50% | 52.22% | -202.63% | 252.67% |
| Cash from Operations | 68.81% | -55.39% | 81.46% | -61.30% | 63.79% |
| Capital Expenditure | -95.81% | 71.51% | -152.71% | 6.80% | -1.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -730.43% | 203.62% | -- | -100.00% | -- |
| Cash from Investing | -3,801.77% | 105.68% | -240.88% | -124.82% | 418.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.70% | 184.15% | -60.05% | 216.54% | -82.10% |
| Repurchase of Common Stock | 34.76% | -172.90% | 9.98% | -12.03% | 22.49% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.01% | -8.71% | 0.14% | 0.62% | -0.89% |
| Other Financing Activities | -2.19% | -37.44% | 14.96% | -94.19% | 67.43% |
| Cash from Financing | 18.02% | -90.20% | -5.46% | 6.37% | -12.68% |
| Foreign Exchange rate Adjustments | -5,920.00% | 92.54% | -101.18% | 106.00% | 138.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.29% | -278.81% | 491.40% | -95.51% | 309.04% |